Gossamer Bio
GOSS
GOSS
100 hedge funds and large institutions have $173M invested in Gossamer Bio in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.53% less ownership
Funds ownership: 80.83% → 77.3% (-3.5%)
19% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 31
Holders
100
Holding in Top 10
1
Calls
$785K
Puts
$579K
Top Buyers
| 1 | +$1.11M | |
| 2 | +$927K | |
| 3 | +$437K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$351K |
| 5 |
Two Sigma Investments
New York
|
+$317K |
Top Sellers
| 1 | -$12M | |
| 2 | -$3.01M | |
| 3 | -$2.43M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.68M |
| 5 |
Goldman Sachs
New York
|
-$1.37M |